Tuesday, March 17, 2026

SM Entertainment Rewards Employees with Stock Grants: A First in Company History

SM Entertainment intends to motivate its workforce for future growth by awarding 50 shares of its stock to most employees

FC Seoul’s Jesse Lingard Voices Frustration Over South Korean Field Conditions

FC Seoul forward Jesse Lingard expressed frustration about the poor condition of the grass on South Korean soccer fields.

At CES 2026, Korean Leaders Call for a Balanced AI Strategy Amid U.S.–China Tech Rivalry

At CES 2026, Korean leaders emphasized a balanced AI strategy to leverage manufacturing strengths amidst U.S.-China competition.

Tag: SB15

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

Top News

- Our Sponsors Ad -

Follow us